Sortera Bio
Company Details
Status: Private
Employees: 11-50
Location:
cambridge, england, united kingdom
Type:
sample
sample
Technology:
sample
sample
About: Sortera Bio is a biotechnology company based in Cambridge, UK, focused on AI-driven biologics discovery. Incorporated in August 2023, it emerged from the MRC Laboratory of Molecular Biology, utilizing intellectual property developed through collaborations, including a partnership with AstraZeneca.
The company specializes in its Deep Screening platform, which generates extensive sequence-function datasets in single experiments. This technology allows for efficient identification of therapeutic candidates with drug-like properties. Sortera combines experimental data with generative AI to enhance biologics development, ensuring robust training datasets and large-scale validation. The company collaborates with pharmaceutical leaders to address complex challenges in biologics, leveraging its expertise in protein engineering and synthetic biology. With a revenue range of £11M–£100M and a team of 11–50 employees, Sortera Bio is positioned at the forefront of machine learning and high-throughput drug discovery.
Unlock access to company contacts, hot leads, and drug pipelines.
Log in or create a free account now!
Sortera Bio | Active clinical trials on ClinicalTrials.gov
Active Clinical Trials Count | 0
No Active Trials Found On ClinicalTrials.gov.